Citation Impact
Citing Papers
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Does Study Design Influence Outcome?
2009
Depression
2018 Standout
Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial
2005
Major depressive disorder
2016 Standout
Placebo Response in Studies of Major Depression
2002
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment
2023
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression
1998
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder
2012
The Placebo Effect: Dissolving the Expectancy Versus Conditioning Debate.
2004 Standout
Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and α1-adrenergic receptor
2009
Etodolac: Efficacy in osteoarthritis and effects on chondrocyte function
1990
Finding cancer in primary care outpatients with low back pain
2001
Should We Expand the Toolbox of Psychiatric Treatment Methods to Include Repetitive Transcranial Magnetic Stimulation (rTMS)?
2010 Standout
How to perform a meta-analysis with R: a practical tutorial
2019 Standout
A Review of the Pharmacological and Clinical Profile of Mirtazapine
2001
Understanding physicians' imaging test use in low back pain care: the role of focus groups
1998
Descending control of pain
2002 Standout
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Randomized controlled trial of education and feedback for implementation of guidelines for acute low back pain
2003
Low Back Pain in Older Adults: Are We Utilizing Healthcare Resources Wisely?
2006
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the guinea pig
2010 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Depression in Late Life: Review and Commentary
2003 Standout
Expenditures and Health Status Among Adults With Back and Neck Problems
2008 Standout
Physician Variation in Diagnostic Testing for Low Back Pain. Who You See Is What You Get
1994
Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs
1988
Chronic Low Back Pain in Older Adults: Prevalence, Reliability, and Validity of Physical Examination Findings
2005
Sarcopenia
2001 Standout
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
PubChem Substance and Compound databases
2015 Standout
Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee
1989
Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs
1991 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Reliability of Physical Examination for Diagnosis of Myofascial Trigger Points
2008 Standout
Drug Treatment of Depression in the 1990s
1996
PubChem3D: Similar conformers
2011
Low Back Pain
2001 Standout
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders
2012
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Hyperforin as a possible antidepressant component of hypericum extracts
1998 Standout
Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls
1989
Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration
1989
Non-specific low back pain
2011 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Overtreating Chronic Back Pain: Time to Back Off?
2009
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
1996
Determination of the R,R- and S,S-enantiomers of vamicamide in human serum and urine by high-performance liquid chromatography on a Chiral-AGP column
1993 StandoutNobel
Low Back Pain: A Twentieth Century Health Care Enigma
1996 Standout
A New Pharmacologic Treatment of Functional Gastrointestinal Disorder: A Double-Blind Placebo-Controlled Study with Mianserin
1996
Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications
2012
The α2-selective adrenoceptor antagonist org 3770 (mirtazapine, Remeron®) enhances noradrenergic and serotonergic transmission
1995
Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians
2008
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Comparison of the effects of etodolac SR and naproxen on gastro-intestinal blood loss
1992
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
2002
Antidepressant Treatment of Depression: A Metaanalysis
1996
Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage
1985
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Etodolac, a new nonsteroidal anti-inflammatory drug: Gastrointestinal microbleeding and endoscopic studies
1989
Effectiveness of Clinical Guidelines in Interventional Pain Management
2002
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents
2000
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
2000 Standout
Haloperidol versus placebo for schizophrenia
2013
Use of Lumbar Radiographs for the Early Diagnosis of Low Back Pain
1997
Low back pain in general practice: reported management and reasons for not adhering to the guidelines in The Netherlands.
2000 Standout
Risperidone versus placebo for schizophrenia
2016
A double‐blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients
1996
A new model of osteoarthritis in rabbits
1983
Industry sponsorship and research outcome
2017 Standout
Experimental Analysis of Neighborhood Effects
2007 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of John Panagides being referenced
Asenapine versus olanzapine in acute mania: a double‐blind extension study
2009
A 3‐week, randomized, placebo‐controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states
2009
Meta‐analysis of randomized, double‐blind, dacebo‐controlled, efficacy and safety studies of mirtazapine versus amitripcyline in major depression
1997
A double-blind, placebo-controlled study comparing mianserin and amitriptyline in moderately depressed outpatients
1994
Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial
2010
A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment
2011
The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis
1988
Utilization of medical services for the treatment of acute low back pain
1992
Pharmacokinetics of mirtazapine from orally administered tablets: influence of a high-fat meal
1997
Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
2010
Dopamine D2 Occupancy as a Biomarker for Antipsychotics: Quantifying the Relationship with Efficacy and Extrapyramidal Symptoms
2010
Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
2010
Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
2010
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
2025
Etodolac compared with aspirin: an endoscopic study of the gastrointestinal tracts of normal volunteers.
1986
Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
1990
P.3.c.010 Asenapine safety and tolerability in acute schizophrenia: a placebo-and risperidone-controlled trial
2006
P.3.c.073 Effects of asenapine on cognitive function in acute schizophrenia: a placebo- and risperidone-controlled trial
2007
Development of new antidepressants.
1997
Inhibition of prostaglandin activity and synthesis by fenbufen (a new nonsteroidal antiinflammatory agent) and one of its metabolites.
1976
Destruction of articular cartilage by arthritic synovium in vitro: Mechaniss of breakdown and effect of indomethacin and prednisolone
1980
A controlled study of mianserin in moderately to severely depressed outpatients.
1991
Efficacy and safety of asenapine in patients with acute exacerbation of schizophrenia
2008